TY - JOUR
T1 - Extracorporeal hepatic resection for advanced liver cancer
AU - Sugimachi, Keishi
AU - Shirabe, Ken
AU - Taketomi, Akinobu
AU - Soejima, Yuji
AU - Uchiyama, Hideaki
AU - Ninomiya, Mizuki
AU - Kayashima, Hiroto
AU - Kitagawa, Dai
AU - Higashi, Hidefumi
AU - Maehara, Yoshihiko
PY - 2010/3/6
Y1 - 2010/3/6
N2 - Hepatic resection is the most curative treatment for the patient with hepatocellular carcinoma (HCC) which occurs in the non-cirrhotic liver. It is not common, but extracorporeal hepatic resection (EHR) is sometimes considered as the treatment of otherwise unresectable tumors due to the location, size, and vascular invasion of the tumor. In the EHR, the liver is completely removed and perfused with the preservation solution. Bloodless transection of hepatic parenchyma is done, and reimplanted in the patient. Preoperative assessment of the vascular anatomy and liver volume, advanced surgical technique of hepatic resection and transplantation, and experienced postoperative care are essential to the accomplishment of EHR. In this issue, we give an outline of the indication, procedures, and the problems of EHR.
AB - Hepatic resection is the most curative treatment for the patient with hepatocellular carcinoma (HCC) which occurs in the non-cirrhotic liver. It is not common, but extracorporeal hepatic resection (EHR) is sometimes considered as the treatment of otherwise unresectable tumors due to the location, size, and vascular invasion of the tumor. In the EHR, the liver is completely removed and perfused with the preservation solution. Bloodless transection of hepatic parenchyma is done, and reimplanted in the patient. Preoperative assessment of the vascular anatomy and liver volume, advanced surgical technique of hepatic resection and transplantation, and experienced postoperative care are essential to the accomplishment of EHR. In this issue, we give an outline of the indication, procedures, and the problems of EHR.
UR - http://www.scopus.com/inward/record.url?scp=79960764909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960764909&partnerID=8YFLogxK
M3 - Article
C2 - 20332674
AN - SCOPUS:79960764909
SN - 0385-0684
VL - 37
SP - 399
EP - 401
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
IS - 3
ER -